Evaluating How Course Modality Influences the Effectiveness of the R3 Academy for Dads

October 12, 2022 updated by: Healthy Relationships California

California Fatherhood: Family-Focused, Interconnected, Resilient, and Essential (Cal-FIRE)

The Cal-FIRE project is designed to offer the R3 Academy for Dads, a robust 24-hour program, to predominantly low-income adult fathers, ages 18 and over in the state of California. The R3 Academy is an evidence-based parenting curriculum that helps fathers strengthen their relationships with their child, with their spouse/co-parent, and at work. The program also includes two evidence-based components that address economic stability and an innovative approach to Case Management that fosters client self-direction. The R3 Academy curricula will be delivered in both English and Spanish through two modalities: 1) live classes and 2) livestream classes via a video conferencing platform. The Local Evaluation will examine how modality, or in other words attending a live class versus a livestream class, influences the effectiveness of responsible fatherhood education when it comes to father involvement and coparenting. The question of modality is a timely one. In the COVID-19 era, many programs have become exclusively online-but the potential impact on effectiveness is not well known. Data from this study will help illuminate what can be gained or jeopardized in a world increasingly moving toward modes of virtual engagement. Specifically, the current evaluation will explore potential similarities and differences related to the implementation of the two modalities and their influence of father outcomes. Specific research questions include:

RQ1: How do live (control) and livestream (treatment) responsible fatherhood workshops compare on father involvement outcomes? RQ2: How do live (control) and livestream (treatment) workshops compare on father involvement outcomes? RQ3: Do program effects last beyond program completion?

Study Overview

Detailed Description

Fathers in this study are required to take an Eligibility survey. If they meet the required eligibility criteria, the survey will gather further information including screening factors associated with domestic violence that, if checked, will be flagged for further assessment by personal contact with our Case Management Supervisor. This form also will enable the registrant to identify which class format he wishes to attend-a live R3 Academy or a livestream workshop via a video conferencing platform. For the purpose of this study, the live or in-person modality is considered the control group and the livestream workshop is considered the treatment group. The R3 Academy curriculum is the same for each group, only the modality of curriculum delivery is different. Courses are a total of 24 hours and are split into either 6- or 12-week formats. Incentives for program completion include a $50 gift card that is offered to those who complete at least 90% of the program. In addition to the Eligibility survey, participants are asked to take a pre-survey before starting the class, a post-survey immediately following class completion, and a 4-month follow-up survey. If participants complete all three surveys they are eligible for an additional $25 gift card which they can receive even if they did not reach 90% completion.

As stated previously, entry into treatment or control groups is determined at enrollment. At the time of the impact analysis, propensity score matching (PSM) comparison groups will be formed-this statistical analysis will match up similar participants from each group to allow for comparison across conditions. PSM allows researchers to estimate differences between treatment and control groups in non-randomized samples. PSM will allow us to directly compare matched cases-meaning that the treatment and control groups will have a similar distribution of sociodemographic and sociocultural characteristics. This allows us to consider how outcomes vary between treatment and control groups, while accounting for the potential self-selection into different program groups. Participants will be matched across multiple metrics, including: racial/ethnic identity, sex/gender, income, education level, language of instruction, number of children, employment status, age, marital status, and residential status. As clients may choose one program delivery modality over another due to work, childcare availability, or time, measures will be included for work schedule, availability of social support, work flexibility, and work-family stress.

Study Type

Interventional

Enrollment (Anticipated)

510

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • California
      • Leucadia, California, United States, 92024
        • Recruiting
        • Healthy Relationships California

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Fathers have to be at least 18 years old with at least one child 24 years old or younger and residing in California.

Exclusion Criteria:

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: NON_RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Livestream Modality
The livestream modality is considered the treatment group for the purpose of this quasi-experimental study.
For this evaluation, the livestream modality is considered the treatment.
EXPERIMENTAL: Live Modality
The live modality is considered the control group for the purpose of this quasi-experimental study.
For this evaluation, the live or in-person modality is considered the control group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Father Involvement after program completion and 4 months following program completion
Time Frame: Data is collected at three time points: (1) before attending the class, (2) immediately after class completion which can be 6 to 12 weeks after baseline depending on the class attended, and (3) 4 months after course completion.
The Fatherhood Research & Practice Network Father Engagement Scale is broken down into two subscales: father caregiving and father support. The father caregiving inquired how frequently fathers participate in a list of activities such as feeding, caring for, or playing with their child. The father support subscale asked how often father participated in activities such as encouraging and talking to their children. Responses are given on a 0=Never to 4=Every day Likert scale.
Data is collected at three time points: (1) before attending the class, (2) immediately after class completion which can be 6 to 12 weeks after baseline depending on the class attended, and (3) 4 months after course completion.
Changes in father's Coparenting after program completion and 4 months following program completion
Time Frame: Data is collected at three time points: (1) before attending the class, (2) immediately after class completion which can be 6 to 12 weeks after baseline depending on the class attended, and (3) 4 months after course completion.
The Fatherhood Research & Practice Network Coparenting Scale is a 10 item scale where father were asked a series of questions related to their coparenting relationships. Answers ranged from 0=strongly disagree to 4=strongly agree.
Data is collected at three time points: (1) before attending the class, (2) immediately after class completion which can be 6 to 12 weeks after baseline depending on the class attended, and (3) 4 months after course completion.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 1, 2022

Primary Completion (ANTICIPATED)

September 30, 2025

Study Completion (ANTICIPATED)

September 30, 2025

Study Registration Dates

First Submitted

September 12, 2022

First Submitted That Met QC Criteria

October 12, 2022

First Posted (ACTUAL)

October 14, 2022

Study Record Updates

Last Update Posted (ACTUAL)

October 14, 2022

Last Update Submitted That Met QC Criteria

October 12, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Anonymized data will be archived with the Inter-university Consortium for Political and Social Research (ICPSR) after we complete our research. The data will not include the participant's name, address, date of birth, phone number, or any other personal information or ID numbers that could identify the participant. Archiving this data provides other researchers with the opportunity to learn about how relationship education benefits people. Information about data archival will be provided on the consent form.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe